Member Info for ria20

...great time to buy today....multi-bagger potential

100,000 all buys

Yes brighty....COO is a great hire and yes longtermers have been averaging down and a lot of new traders see the great potential here and taking positions too.....good time to be here

Agree scmdcyp

Looking very positive for a break out this week

Up 23 percent now and primed to break past 2.00

Jealous and is a deramper and says the same few lines everyday .....hoping to scare people off....it doesn't work petroinvestor....look at PYC....my technical analysis was correct and is 100 percent up from last weeks price when i said BUY...

Looking very strong ....great time to buy ....

Great start this morning expect POS and LEND (Worth a look too) ............to have a fabulous day ...i am 130 percent up on POS....Great start to the week would love to see POS breaa 15.00 this week and LEND to break past 2.00

Now

This morning and strong buying pressure....should be another fabulous day upwards

10 percent ....great opening 30 minutes

8 percent now

On the leaderboard

Up 5 percent

Physiomics

One of the rules of a small cap bear market is that companies have to pull rabbits out of hats, to surprise investors with good news. Physiomics (PYC) managed to do this off the back of a fresh contract with pharma giant Merck. The shares of the oncology drug development group rose 61% on the week. But perhaps given the way the company was already dealing with a massive counterparty, one wonders why the market had not already given the now £2m market cap company a higher value? Perhaps it will get on with doing this from now.

Today 07:00

RNS Number : 2013L

Physiomics PLC

04 September 2023

4 September 2023

Physiomics plc

("Physiomics" or "the Company")

Senior Management Update

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to announce the hiring of a new member of its senior management team. Effective today, Dr Peter Sargent will be joining the Company as Chief Operating Officer ("COO").

Prior to joining us, Dr Sargent held a senior management role at global consultancy business Syneos Health Inc (NASDAQ: SYNH), leading large teams of professionals and servicing a variety of clients in the biopharmaceuticals space. Among his earlier roles, Dr Sargent has also been Head of Business Development for the UK's National Institute for Health and Care Research (NIHR), leading a team supporting global life science businesses access to funding and research infrastructure in the UK.

The COO role will help to formulate the Company's overall business strategy and play a pivotal role in driving its execution. The initial focus will be to strengthen the operational performance of the Company and in particular drive the key priorities announced during the Company's recent placing, namely:

· further expansion and diversification of its client base;

· expansion of its consulting business into the adjacent area of pharmaceutical biostatistics services; and

· exploration of opportunities around its personalised oncology software offering.

Dr Sargent will join as a key member of the Company's senior leadership team (but not as a board director) and will report directly to Dr Jim Millen. The hiring of Dr Sargent forms part of a strategy to revert to a more traditional board structure where the roles of Executive Chairman and CEO are separated.

Executive Chairman & CEO, Dr Jim Millen, commented:

"I am delighted that Physiomics has been able to attract a candidate of the calibre of Dr Peter Sargent, who joins us with significant experience of building service businesses in the biopharmaceutical sector. Peter will work closely with myself and my senior management team to set and drive forwards the Company's key business priorities and I look forward to him making a significant positive impact."

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

Hybridan LLP (Broker)

Claire Louise Noyce

+44 (0) 203 764 2341

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

+44 (0)20 7409 3494

Petroinvestor....i call it technical analysis and charting and i am correct again .......100 percent since i said buy......shame on you .....that you did not listen, otherwise you would make some too .....but no you want to people to sell and you are a hater and jealous person and don't want this share to rise....we all know your agenda...........so shut up before we all report you for being abusive/disruptive on a board that you are not invested

Incoming.... this has a long way to climb yet....multi-bagger and today is another fabulous RNS

100 percent up....great start